Advances in Dermatology and Allergology
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2025
vol. 42
 
Share:
Share:
Original paper

Management of women with hirsutism in Kosovo

Besa Gacaferri Lumezi
1
,
Violeta Lokaj-Berisha
1

  1. Department of Physiology and Immunology, Faculty of Medicine, University of Prishtina “Hasan Prishtina” Bulevardi i Deshmoreve p.n., Prishtina, Kosovo
Adv Dermatol Allergol 2025; XLII (6): 565–571
Online publish date: 2026/01/12
Article file
- Management of women.pdf  [0.13 MB]
Get citation
 
 
1. Armata I, Prakash A. An update on the assessment and management of hirsutism. Obstet Gynecol Reprod Med 2024; 34: 81-7.
2. Elliott J, Liu K, Motan T. Guideline No. 444: hirsutism: evaluation and treatment. J Obstet Gynaecol Can 2023; 45: 102272.
3. Vaidya T, Hohman MH, Kumar D. Laser Hair Removal. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 25, 2023.
4. Bhat YJ, Bashir S, Nabi N, et al. Laser treatment in hirsutism: an update. Dermatol Pract Concept 2020; 10: e2020048.
5. López-Alarcón M, Vital-Reyes VS, Almeida-Gutiérrez E, et al. Obesity and hyperandrogenemia in polycystic ovary syndrome: clinical implications. J Pers Med 2023; 13: 1319.
6. Sahin Y, Kelestimur F. Medical treatment regimens of hirsutism. Reprod Biomed Online 2004; 8: 538-46.
7. Hafsi W, Kaur J. Hirsutism. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 3, 2023.
8. Forslund M, Melin J, Alesi S, et al. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol 2023; 189: S1-16.
9. Shah D, Patil M. National PCOS Working Group. Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India. J Hum Reprod Sci 2018; 11: 96-118.
10. Mihailidis J, Dermesropian R, Taxel P, et al. Endocrine evaluation of hirsutism. Int J Womens Dermatol 2017; 3: S6-10.
11. Forslund M, Melin J, Alesi S, et al. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review. Clin Endocrinol 2023; 99: 79-91.
12. Wooltorton E. Diane-35 (cyproterone acetate): safety concerns. CMAJ 2003; 168: 455-6.
13. Alesi S, Forslund M, Melin J, et al. Correction of meta-analysis after retraction of article on the effects of anti-androgens in polycystic ovary syndrome. EClinicalMedicine 2024; 79: 103009.
14. Tahvilian R, Ebrahimi A, Beiki O, et al. Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic Hirsutism. J Drug Assess 2015; 4: 12-8.
15. Soares Júnior JM, Guimarães DZ, Simões RDS, et al. Systematic review of finasteride effect in women with hirsutism. Rev Assoc Med Bras (1992) 2021; 67: 1043-9.
16. Oliveira-Soares R, André MC, Peres-Correia M. Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women. Int J Trichol 2018; 10: 48-50.
17. Fraison E, Kostova E, Moran LJ, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev 2020; 8: CD005552.
18. Barrionuevo P, Nabhan M, Altayar O, et al. Treatment options for hirsutism: a systematic review and network meta-analysis. J Clin Endocrinol Metab 2018; 103: 1258-64.
19. Sachdeva S. Hirsutism: evaluation and treatment. Indian J Dermatol 2010; 55: 3-7.
20. Agrawal NK. Management of hirsutism. Indian J Endocrinol Metab 2013; 17: S77-82.
21. Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018; 103: 1233-57.
22. Castelo-Branco C, Cancelo MJ. Comprehensive clinical management of hirsutism. Gynecol Endocrinol 2010; 26: 484-93.
23. Vaidya T, Hohman MH, Kumar DD. Laser Hair Removal. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 25, 2023.
24. van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Datab Syst Rev 2015; 4: CD010334.
25. Bazarganipour F, Ziaei S, Montazeri A, et al Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome. Iran J Reprod Med 2013; 11: 829-36.
26. Harrington AG, Overall NC. Women’s attractiveness contingent self-esteem, romantic rejection, and body dissatisfaction. Body Image 2021; 39: 77-89.
27. Chishti SH, Rafiq M. Psychosocial issues, coping strategies and psychological symptoms of hirsute women. Pak J Med Res 2019; 58: 141-8.
28. Matheson E, Bain J. Hirsutism in women. Am Fam Physician 2019; 100: 168-75.
29. Agrawal NK. Management of hirsutism. Indian J Endocrinol Metab 2013; 17: S77-82.
30. Spritzer PM, Marchesan LB, Santos BR, et al. Normal androgens and diagnosis of PCOS. Diagnostics 2022; 12: 1922.
31. Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med 2023; 2: e000548.
32. S³opieñ R, Milewska E, Rynio P, et al. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age. Prz Menopauzalny 2018; 17: 1-4.
33. Markovski M, Hall J, Jin M, et al. Approach to the management of idiopathic hirsutism. Can Fam Physician 2012; 58: 173-7.
34. Mihailidis J, Dermesropian R, Taxel P, et al. Endocrine evaluation of hirsutism. Int J Womens Dermatol 2017; 3: S6-10.
35. Cumming DC, Yang JC, Rebar RW, et al. Treatment of hirsutism with spironolactone. JAMA 1982; 247: 1295-8.
36. Sachdeva S. Hirsutism: evaluation and treatment. Indian J Dermatol 2010; 55: 3-7.
37. Soares Júnior JM, Guimarães DZ, Simões RDS, et al. Systematic review of finasteride effect in women with hirsutism. Rev Assoc Med Bras 2021; 67: 1043-9.
38. Hunter MH, Carek PJ. Evaluation and treatment of women with hirsutism. Am Fam Physician 2003; 67: 2565-72.
39. Luque-Ramírez M, Nattero-Chávez L, Ortiz Flores AE, et al. Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2018; 24: 225-41.
40. Ezeh U, Huang A, Landay M, et al. Long-term response of hirsutism and other hyperandrogenic symptoms to combination therapy in polycystic ovary syndrome. J Womens Health 2018; 27: 892-902.
41. Eisenhardt S, Schwarzmann N, Henschel V, et al. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2006; 91: 946-52.
42. Rivkees SA. Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the “growth toxic” glucocorticoid. Int J Pediatr Endocrinol 2010; 2010: 569680.
43. Rababa’h AM, Matani BR, Yehya A. An update of polycystic ovary syndrome: causes and therapeutics options. Heliyon 2022; 8: e11010.
44. Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity. BMC Endocr Disord 2023; 23: 14.
45. Armata I, Prakash A. An update on the assessment and management of hirsutism. Obstet Gynaecol Reprod Med 2024; 34: p81-7.
46. Hendricks K, Nxumalo CT, Makgobole MU, et al. Evaluating the effectiveness of laser hair reduction using a home use laser in comparison to a diode laser. PLoS One 2023; 18: e0286162.
47. Nistico SP, Bennardo L, Bennardo S, et al. Comparing traditional and in motion Nd:YAG laser in hair removal: a prospective study. Medicina (Kaunas) 2022; 58: 1205.
48. Bhat YJ, Bashir S, Nabi N, et al. Laser treatment in hirsutism: an update. Dermatol Pract Concept 2020; 10: e2020048.
49. Saad A, Mohammed J, Ziad M, et al. Hyperpigmentation post laser hair removal in patients taking vitamin D supplements. J Dermatol Dermatol Surg 2021; 25: 33-6.
50. Hosseini MS, Ehsani AH, Fakour Y, et al. Effect of laser-assisted hair removal (LAHR) on the quality of life and depression in hirsute females: a single-arm clinical trial. J Lasers Med Sci 2022; 13: e46.
51. Lee CM. Laser-assisted hair removal for facial hirsutism in women: a review of evidence. J Cosmet Laser Ther 2018; 20: 140-4.
52. Bordewijk EM, Ng KYB, Rakic L, et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2020; 2: CD001122.
53. Davies S. Hirsutism and quality of life. In: Handbook of Disease Burdens and Quality of Life Measures. Preedy VR, Watson RR (eds.). Springer, New York, NY 2010.
54. Alur-Gupta S, Dokras A, Cooney LG. Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms. Fertil Steril 2024; 121: 384-99.
55. Rajashekar S, Giri Ravindran S, Kakarla M, et al. Spironolactone versus oral contraceptive pills in the treatment of adolescent polycystic ovarian syndrome: a systematic review. Cureus 2022; 14: e25340.
56. Fischer B, Gleason C, Asthana S. Effects of hormone therapy on cognition and mood. Fertil Steril 2014; 101: 898-904.
57. Hodeeb YM, Dinary AM, Hassan MH, et al. Hirsutism and health related quality of life. Mod Chem Appl 2015; 3: 4.
58. Prabakar AD. The power of thought: the role of psychological attentiveness and emotional support in patient trajectories. Yale J Biol Med 2024; 97: 3.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2026 Termedia Sp. z o.o.
Developed by Bentus.